Fabry disease: open trials in Spain

• NCT06904261

  A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants

  Trial Treatment · Phase 3 · Amicus Therapeutics

  Hospital Universitario de la Paz, Madrid

  Registry updated 2026-10-22

• NCT00196742

  Fabry Disease Registry & Pregnancy Sub-registry

  Research · Genzyme, a Sanofi Company

  A Coruña · A Coruña · Barcelona · Barcelona · Barcelona · Barcelona · Barcelona · Bizkaia · L'Hospitalet de Llobregat · Tarragona · Vigo

  Registry updated 2026-10-14

• NCT06328608

  A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease

  Trial Treatment · Phase 2/3 · Chiesi Farmaceutici S.p.A.

  Complexo Hospitalario Universitario De Santiago, Santiago de Compostela

  Registry updated 2026-08-10

• 2025-521244-38-00

  An Open-label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of 12-month Treatment with Migalastat in Pediatric Subjects (aged 2 to < 12 years) with Fabry Disease and Amenable GLA Variants

  Trial Treatment · Phase 3 · Amicus Therapeutics Inc.

  Hospital Universitario La Paz, Madrid

  Registry updated 2026-04-24

• NCT06941025

  Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

  Research · Chiesi Farmaceutici S.p.A.

  No physical study sites - Decentralized, web-based registry, Madrid

  Registry updated 2026-03-19

All Fabry disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error